Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Contract

1 Apr 2021 07:00

RNS Number : 2078U
Galliford Try Holdings PLC
01 April 2021
 

GALLIFORD TRY APPOINTED TO SCOTTISH WATER £700m FRAMEWORK

Galliford Try, one of the UK's leading construction groups, announces that its Environment business has been appointed to Scottish Water's new Non-Infrastructure Framework for the SR21-27 investment programme, in joint venture with MWH Treatment.

The new framework is valued at £700m over a six-year time frame beginning this year, and will see the 50:50 joint venture, known as ESD, support the capital delivery functions of Scottish Water, providing process design and build solutions for water and wastewater treatment works across Scotland.

The previous ESD joint venture delivered over 150 projects for Scottish Water during the six-year SR15 investment programme.

Bill Hocking, Chief Executive of Galliford Try, commented: "The water sector remains a key focus for the infrastructure side of our business and I am delighted that we have renewed our position on this framework. We are a long-term partner for Scottish Water and look forward to continuing our excellent relationship, providing high-quality solutions for their investment programme needs."

 

Galliford Try

 

Bill Hocking, Chief Executive 01895 855001

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

 

Notes to Editors 

Galliford Try is a trading name of Galliford Try Holdings plc, a leading UK construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTMZGFFNMKGMZM
Date   Source Headline
12th Oct 20227:00 amRNSTransaction in Own Shares
11th Oct 20227:00 amRNSTransaction in Own Shares
10th Oct 20224:00 pmRNSAnnual Financial Report
7th Oct 20224:00 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSTransaction in Own Shares
4th Oct 20227:00 amRNSTotal Voting Rights
3rd Oct 20227:00 amRNSTransaction in Own Shares
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
28th Sep 20225:30 pmRNSDirector/PDMR Shareholding
28th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20225:03 pmRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20224:45 pmRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSTransaction in Own Shares
22nd Sep 20223:00 pmRNSEmployee Share Trust Trading Plan
22nd Sep 20227:00 amRNSTransaction in Own Shares
21st Sep 20227:01 amRNSLaunch of Share Buyback Programme
21st Sep 20227:00 amRNSFinal Results
1st Aug 20227:00 amRNSContract
14th Jul 20227:00 amRNSTrading Statement
11th Jul 20227:00 amRNSAcquisition of MCS Control Systems
1st Jul 202211:00 amRNSDirector Declaration
23rd Jun 20227:00 amRNSContract
31st May 20227:00 amRNSTotal Voting Rights
30th May 202210:00 amRNSExercise of share options
10th May 20227:00 amRNSBusiness Briefing
26th Apr 20227:00 amRNSAppointment of Director
1st Apr 20229:10 amRNSConfirmation of Directorate Change
15th Mar 20227:00 amRNSDirectorate Change
4th Mar 20225:03 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSHalf-year Results
9th Feb 20227:00 amRNSContract
19th Jan 20227:00 amRNSTrading Update
31st Dec 202112:36 pmRNSPrice Monitoring Extension
23rd Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 202111:51 amRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSContract
12th Nov 20214:01 pmRNSResult of AGM
12th Nov 20217:00 amRNSAGM Statement
7th Oct 20213:23 pmRNSAcquisition
7th Oct 202110:27 amRNSDirector Declaration
6th Oct 20217:00 amRNSContract
5th Oct 20214:47 pmRNSAnnual Financial Report
23rd Sep 20214:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20214:00 pmRNSDirector/PDMR Shareholding
17th Sep 20211:00 pmRNSEmployee Share Trust Trading Plan
16th Sep 20217:00 amRNSFinal Results
26th Aug 20213:42 pmRNSHolding(s) in Company
16th Aug 202110:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.